Haoxi Health Technology Limited
HAO | NASDAQ
$2.75
-$0.14 (-4.84%)
At close: Sep 21, 2026, 4:00 PM ET
$2.84
+$0.09 (+3.27%)
Pre-market:
Sep 22, 2026, 5:16 AM ET
Fiscal Year Period Ending | FY 2025 Jun 29, 2025 | FY 2024 Jun 29, 2024 | FY 2023 Jun 29, 2023 | FY 2022 Jun 29, 2022 | FY 2021 Jun 29, 2021 |
|---|---|---|---|---|---|
Revenue | 32.8M | 48.52M | 28.23M | 16.16M | 12.85M |
Cost of Revenue | 31.88M | 45.77M | 26.17M | 15.51M | 12.24M |
Gross Profit | 927.75K | 2.75M | 2.06M | 648.72K | 605.58K |
Operating Income | -2M | 1.72M | 1.2M | 268.77K | 330.55K |
Interest Income | 363.31K | 76.1K | n/a | n/a | n/a |
Pretax Income | 4.15M | 1.74M | 1.19M | 259.6K | 325.28K |
Net Income | 3.88M | 1.29M | 969.75K | 244.59K | 304.07K |
Selling & General & Admin | 2.85M | 953.14K | 808.09K | 277.43K | 212.38K |
Research & Development | 79.54K | 79.99K | 58.16K | 102.52K | 62.65K |
Other Expenses | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 2.93M | 1.03M | 866.26K | 379.95K | 275.02K |
Interest Expense | 45.96K | 41.19K | 20.9K | 9.96K | 5.27K |
Selling & Marketing Expenses | 50.18K | 41.61K | 32.13K | 37.49K | 42.66K |
Cost & Expenses | 34.8M | 46.8M | 27.03M | 15.89M | 12.52M |
Income Tax Expense | 270.74K | 443.58K | 220.65K | 15.01K | 21.22K |
Shares Outstanding (Basic) | 116.71K | 612K | 552.27K | 500K | 500K |
Shares Outstanding (Diluted) | 119.85K | 612K | 552.27K | 500K | 500K |
EPS (Basic) | 33.20 | 21.20 | 1.76 | 0.48 | 0.60 |
EPS (Diluted) | 26.40 | 21.20 | 1.76 | 0.48 | 0.60 |
EBITDA | 4.57M | 1.79M | 1.22M | 271.77K | 330.97K |
EBIT | 4.19M | 1.78M | 1.21M | 269.56K | 330.55K |
Depreciation & Amortization | 371.76K | 10.57K | 8.39K | 2.21K | 411 |
Add to Watchlist
Select watchlists to add or remove HAO